Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

68Gallium Citrate Imaging in Newly Diagnosed Hepatocellular Carcinoma

NCT03116945 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT03116945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03116945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
68Gallium Citrate Imaging in Newly Diagnosed Hepatocellular Carcinoma
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2016
Completion date
December 31, 2020
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma